TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
PE Bioprocess Consulting AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
287
|
216
|
396 |
Financial expenses |
0
|
14
|
0 |
Earnings before taxes |
12
|
210
|
176 |
EBITDA |
4
|
-46
|
111 |
Total assets |
603
|
656
|
617 |
Current assets |
361
|
430
|
342 |
Current liabilities |
58
|
64
|
126 |
Equity capital |
545
|
592
|
492 |
- share capital |
101
|
95
|
98 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
90.4%
|
90.2%
|
79.7% |
Turnover per employee |
287
|
216
|
396 |
Profit as a percentage of turnover |
4.2%
|
97.2%
|
44.4% |
Return on assets (ROA) |
2.0%
|
34.1%
|
28.5% |
Current ratio |
622.4%
|
671.9%
|
271.4% |
Return on equity (ROE) |
2.2%
|
35.5%
|
35.8% |
Change turnover |
56
|
-168
|
321 |
Change turnover % |
24%
|
-44%
|
427% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.